Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-9-7
pubmed:abstractText
We have previously reported that administration of granulocyte colony-stimulating factor (G-CSF)+Flt-3 ligand (FL) or G-CSF+stem cell factor (SCF) improves left ventricular (LV) function and halts LV remodeling at 35 d after myocardial infarction (MI). In the current study, we investigated whether these beneficial effects are sustained in the long term - an issue of fundamental importance for clinical translation. Mice undergoing a 30-min coronary occlusion followed by reperfusion received vehicle (group I), G-CSF+FL (group II), G-CSF+SCF (group III), or G-CSF alone (group IV) starting 4 h after reperfusion and were euthanized 48 wk later. LV structure and function were assessed by serial echocardiography before and at 48 h and 4, 8, 16, 32, and 48 wk after MI. During follow-up, mice in group I exhibited worsening of LV function and progressive LV remodeling. Compared with group I, both groups II and III exhibited improved LV EF at 4 wk after MI; however, only in group II was this improvement sustained at 48 wk. Group II was also the only group in which the decrease in infarct wall thickening fraction, the LV dilatation, and the increase in LV mass were attenuated vs. group I. We conclude that the beneficial effect of G-CSF+FL on postinfarction LV dysfunction and remodeling is sustained for at least 11 months, and thus is likely to be permanent. In contrast, the effect of G-CSF+SCF was not sustained beyond the first few weeks, and G-CSF alone is ineffective. To our knowledge, this is the first long-term study of cytokines in postinfarction LV remodeling. The results reveal heretofore unknown differential actions of cytokines and have important translational implications.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/HL-55757, http://linkedlifedata.com/resource/pubmed/grant/HL-70897, http://linkedlifedata.com/resource/pubmed/grant/HL-76794, http://linkedlifedata.com/resource/pubmed/grant/HL-78825, http://linkedlifedata.com/resource/pubmed/grant/HL-89939, http://linkedlifedata.com/resource/pubmed/grant/P01 HL078825-04, http://linkedlifedata.com/resource/pubmed/grant/P01 HL078825-05, http://linkedlifedata.com/resource/pubmed/grant/R01 HL-72410, http://linkedlifedata.com/resource/pubmed/grant/R01 HL070897-04, http://linkedlifedata.com/resource/pubmed/grant/R01 HL070897-05, http://linkedlifedata.com/resource/pubmed/grant/R01 HL072410-04, http://linkedlifedata.com/resource/pubmed/grant/R01 HL076794-03, http://linkedlifedata.com/resource/pubmed/grant/R01 HL076794-04, http://linkedlifedata.com/resource/pubmed/grant/R01 HL089939-01A1, http://linkedlifedata.com/resource/pubmed/grant/R21 HL-89737, http://linkedlifedata.com/resource/pubmed/grant/R21 HL089737-01A1, http://linkedlifedata.com/resource/pubmed/grant/R37 HL055757-13, http://linkedlifedata.com/resource/pubmed/grant/R37 HL055757-14
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1095-8584
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
528-35
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up.
pubmed:affiliation
Institute of Molecular Cardiology, University of Louisville, Division of Cardiovascular Medicine, 550 S. Jackson St., ACB, 3rd Floor, Louisville, KY 40292, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural